Briefly, high FAP expression of both tumor cells and CAFs was frequently found in the patients with solid predominant adenocarcinoma (53.8% in tumor cells and 61.5% in CAFs, respectively) than other subtypes of adenocarcinoma. The gene discussed is FAP; the disease is adenocarcinoma.